tiprankstipranks
Advertisement
Advertisement
Tandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle
PremiumThe FlyTandem Diabetes launches t:slim X2 compatibility with Abbott’s FreeStyle
1M ago
Tandem Diabetes initiated with a Hold at Deutsche Bank
Premium
The Fly
Tandem Diabetes initiated with a Hold at Deutsche Bank
1M ago
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
Premium
Ratings
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
2M ago
Tandem Diabetes price target lowered to $17 from $22 at Citi
PremiumThe FlyTandem Diabetes price target lowered to $17 from $22 at Citi
2M ago
Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
Premium
The Fly
Tandem Diabetes price target lowered to $21 from $24 at Goldman Sachs
2M ago
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
Premium
Company Announcements
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
2M ago
Tandem Diabetes initiated with a Hold at Benchmark
PremiumThe FlyTandem Diabetes initiated with a Hold at Benchmark
3M ago
Tandem Diabetes initiated with a Hold at Benchmark
Premium
The Fly
Tandem Diabetes initiated with a Hold at Benchmark
3M ago
Tandem Diabetes price target lowered to $55 from $56 at Barclays
Premium
The Fly
Tandem Diabetes price target lowered to $55 from $56 at Barclays
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100